Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 47,000 full-time employees.  Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing efforts, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer. The company is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD).

Eli Lilly & Co. terlibat dalam penemuan, pengembangan, pembuatan, dan penjualan produk farmasi. Perusahaan ini berkantor pusat di Indianapolis, Indiana dan saat ini mempekerjakan 47.000 karyawan penuh waktu. Produk kesehatan kardiometaboliknya meliputi Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, dan lainnya; Humulin, Humulin 70/30, dan lainnya; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, dan VERVE-301. Produk onkologi-nya termasuk Cyramza, Erbitux, Tyvyt, dan Verzenio. Produk imunologinya meliputi Ebglyss, Olumiant, Omvoh, dan Taltz. Produk neuro ilmiah-nya termasuk Emgality dan Kisunla. Perusahaan ini, melalui anak perusahaannya, POINT Biopharma Global Inc., terlibat dalam penemuan, pengembangan, dan upaya pembuatan radiopharmaceutical, serta terapi radioligand klinis dan pra-klinis yang sedang dikembangkan untuk pengobatan kanker. Perusahaan ini juga sedang mengembangkan penghambat molekul kecil oral a4b7 integrin untuk penyakit radang usus (IBD).

Eli Lilly

NVIDIA

Apple

Microsoft

Google

Amazon

Broadcom

Meta Platforms

Taiwan Semiconductor

Tesla

Berkshire Hathaway

JPMorgan

Walmart

Visa

Oracle

Exxon Mobil

MasterCard

Johnson & Johnson

Netflix

SPDR S&P500 ETF

AbbVie

Palantir

Costco

ASML

Bank of America

Alibaba

Home Depot

Procter & Gamble

General Electric

Chevron

Cisco

Coca-Cola

Vanguard Total Stock Market ETF

UnitedHealth Group

AstraZeneca

Micron Technology

Wells Fargo

Caterpillar

Toyota

Morgan Stanley

Novartis

T-Mobile

Philip Morris

American Express

Raytheon Technologies

Goldman Sachs

Salesforce

Merck

Abbott

McDonald's

Shell

Novo Nordisk

Royal Bank of Canada

Shopify

PepsiCo

Invesco QQQ Trust

Intuitive Surgical

Linde PLC

Uber

Disney

Lam Research

Amgen

Intuit

AT&T

Citigroup

Applied Materials

NextEra Energy

QUALCOMM

ServiceNow

Sony

Verizon

Intel

Blackstone

Charles Schwab

Arista Networks

BlackRock

Danaher

Booking Holdings

Banco Santander

Gilead Sciences

Accenture

Boston Scientific

S&P Global

Unilever

Boeing

Texas Instruments

Pfizer

Toronto-Dominion Bank

TotalEnergies

Palo Alto Networks

Adobe

CrowdStrike

Spotify

Progressive

Saham Eli Lilly

Tentang Eli Lilly

Statistik Kunci